Is budesonide (corticosteroid) inhaler safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Budesonide Inhaler Safety During Pregnancy

Budesonide inhaler is safe and recommended for use during pregnancy, as it has the most safety data among inhaled corticosteroids and is classified as FDA Pregnancy Category B. 1, 2

Safety Profile of Budesonide in Pregnancy

  • Budesonide is the preferred inhaled corticosteroid (ICS) during pregnancy due to extensive safety data compared to other ICS medications 3, 2
  • At usual doses, budesonide has not been associated with increased risk of major malformations, intrauterine growth restriction (IUGR), preterm delivery, or low birth weight 3
  • FDA classifies budesonide as Pregnancy Category B, indicating no evidence of risk in humans 2, 4
  • The Swedish Medical Birth Registry data shows no increased risk for congenital malformations from inhaled budesonide use during early pregnancy 1
  • A randomized controlled study found no significant difference in adverse pregnancy outcomes between women using low-dose budesonide versus placebo 5

Importance of Asthma Control During Pregnancy

  • Maintaining asthma control during pregnancy is critical for maternal and fetal well-being 3, 2
  • Uncontrolled asthma poses greater risks to mother and fetus than potential medication risks, including:
    • Increased risk of perinatal mortality 3
    • Higher rates of pre-eclampsia 3, 6
    • Greater likelihood of preterm birth 3, 6
    • Increased risk of low birth weight infants 3, 6
  • It is safer for pregnant women to be treated with appropriate asthma medications than to have uncontrolled asthma symptoms and exacerbations 3, 6

Clinical Recommendations for Budesonide Use in Pregnancy

  • Continue budesonide inhaler if already being used before pregnancy 3, 2
  • For patients requiring initiation of ICS therapy during pregnancy, budesonide is the preferred option 2, 4
  • Use the lowest effective dose necessary to maintain asthma control 3, 2
  • Monitor asthma symptoms regularly throughout pregnancy, as asthma can improve in 1/3 of women and worsen in 1/3 during pregnancy 3, 6
  • Monthly evaluations of asthma control and lung function are recommended during prenatal visits 3

Comparison with Other Inhaled Corticosteroids

  • While budesonide has the most safety data in pregnancy, other ICS medications have not been proven unsafe 3, 2
  • If a woman's asthma was well-controlled with another ICS before pregnancy, it is acceptable to continue that medication 3, 2
  • Beclomethasone also has substantial pregnancy safety data and can be considered as an alternative 3
  • For newer ICS medications with less pregnancy data (ciclesonide, mometasone), benefit-risk assessment should favor continuing if they were effective before pregnancy 3

Common Pitfalls to Avoid

  • Discontinuing asthma medications during pregnancy due to unfounded safety concerns, which can lead to poor asthma control and increased risks to mother and fetus 2, 6
  • Undertreatment of asthma symptoms during pregnancy, which can result in exacerbations requiring systemic corticosteroids that carry higher risks than inhaled medications 6, 4
  • Failing to monitor asthma control regularly throughout pregnancy, as the course of asthma can change unpredictably during this period 3, 6
  • Switching from an effective ICS unnecessarily if the patient was previously well-controlled 3, 2

In conclusion, budesonide inhaler is safe during pregnancy and should be used when indicated to maintain optimal asthma control, as the risks of uncontrolled asthma far outweigh any potential risks of the medication.

References

Guideline

Budesonide/Formoterol Use During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treating asthma and comorbid allergic rhinitis in pregnancy.

Journal of the American Board of Family Medicine : JABFM, 2007

Research

Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2005

Research

Asthma during Pregnancy: Exacerbations, Management, and Health Outcomes for Mother and Infant.

Seminars in respiratory and critical care medicine, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.